ID
13603
Beschreibung
Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00510939
Link
https://clinicaltrials.gov/show/NCT00510939
Stichworte
Versionen (1)
- 19.02.16 19.02.16 -
Rechteinhaber
CC BY-NC 3.0
Hochgeladen am
19. Februar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Acute Myeloid Leukemia NCT00510939
Eligibility Acute Myeloid Leukemia NCT00510939
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschreibung
1. serum bilirubin 2 x> upper limit of normal (uln)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1278039
Beschreibung
2. aspartate aminotransferase (ast/sgot) or alanine aminotransferase (alt/sgpt) >3.5 x uln
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0201836
- UMLS CUI [2]
- C0201899
Beschreibung
3. serum creatinine ³ 2.5 x uln or 24-hour creatinine clearance £ 60 ml/min (measured or calculated by cockcroft-gault)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0201976
- UMLS CUI [2]
- C0373595
Beschreibung
4. patients with aml of fab m3 classification (apl)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0023487
Beschreibung
5. patients with a history of another primary malignancy within the previous 1 year other than basal cell carcinoma or carcinoma in situ, the patient is in remission
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschreibung
6. any clinically defined central nervous system aml.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1332884
- UMLS CUI [2]
- C0023467
Beschreibung
7. participation in an investigational drug study within the 30 days prior to entry
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschreibung
8. evidence of uncontrolled infection or cns-hemorrhagic
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschreibung
9. patients with documented cases of human immunodeficiency virus (hiv)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019682
Beschreibung
10. peripheral neuropathy or neuropathic pain grade > or = 2
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0031117
- UMLS CUI [2]
- C0458960
Beschreibung
11. has known or suspected hypersensitivity or intolerance to boron, mannitol, or heparin, if an indwelling catheter is used
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0006030
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C0024730
- UMLS CUI [3,1]
- C0020517
- UMLS CUI [3,2]
- C0019134
Beschreibung
12. uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrollment, new york heart association (nyha) class iii or iv heart failure (attachment 7,nyha classification of cardiac disease), uncontrolled angina, clinically significant pericardial disease, or cardiac amyloidosis
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0018799
Beschreibung
13. rasgrp1/aptx gene expression ratio calculated at the screening <10 (part b.2 only)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1419283
- UMLS CUI [2]
- C1423885
Ähnliche Modelle
Eligibility Acute Myeloid Leukemia NCT00510939
- StudyEvent: Eligibility
C0023467 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C3841806 (UMLS CUI [3,2])
C0035020 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
C1423885 (UMLS CUI [2])
C0201899 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
C0023467 (UMLS CUI [2])
C0458960 (UMLS CUI [2])
C0006030 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0024730 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0019134 (UMLS CUI [3,2])
C1423885 (UMLS CUI [2])
Keine Kommentare